Dna X (SONM) Retained Earnings (2018 - 2026)

Dna X (SONM) has 9 years of Retained Earnings data on file, last reported at -$297.6 million in Q1 2026.

• Quarterly Retained Earnings fell 205.51% year-over-year to -$297.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$297.6 million (down 205.51% YoY) and the FY2025 annual result came in at $296.3 million, up 6.62% from the prior year.
• Retained Earnings eased to -$297.6 million in Q1 2026, from $296.3 million in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of $296.3 million in Q4 2025 to a low of -$297.6 million in Q1 2026.
• A 5-year average of $28.5 million and a median of $270.3 million in 2023 frame the typical range for Retained Earnings.
• Annual changes were most pronounced in 2022 — Retained Earnings tumbled 205.56% — and 2025, when it surged 212.47%.
• Tracing SONM's Retained Earnings over 5 years: stood at -$249.9 million in 2022, then dropped by 0.04% to -$250.0 million in 2023, then surged by 211.18% to $277.9 million in 2024, then advanced by 6.62% to $296.3 million in 2025, then tumbled by 200.43% to -$297.6 million in 2026.
• The last three Retained Earnings figures came in at -$297.6 million (Q1 2026), $296.3 million (Q4 2025), and $294.7 million (Q3 2025), per Business Quant data.